PO Garibaldi-Nesima, ARNAS Garibaldi

Catania 6 trials 4 recruiting

6 Registered trials

4 Currently recruiting

Organisation

PO Garibaldi-Nesima, ARNAS Garibaldi

Location

Catania, Italy

Identifier

ORL-000005304

Address

Via Palermo 636, 95122, Italy

Departments

Ematologia
IT30014:U.O.C di Ematologia
U.O.C. Ematologia
U.O.C. Oncologia Medica
U.O.C. Oncologia Medica P.O.Garibaldi Nesima , Catania

Clinical trials at this site (6)

Search interface

Efficacy and Safety of Luspatercept for the Treatment of Anemia Due to Myelodysplastic Syndromes with del5q refractory/resistant/intolerant … Recruiting

2024-519310-31-00 Anemia due to MDS with del5q with IPSS-R very low, low, 4 2025-01-27
MITO 31- A phase II trial of Olaparib in patients with recurrent ovarian cancer wild type for germline and somatic BRCA 1 and 2 genes: The M… Recruiting

2024-516841-38-00 recurrent ovarian cancer wild type for germline and som 4 2025-01-09
Olaparib beyond progression compared to platinum chemotherapy after secondary cytoreductive surgery in recurrent ovarian cancer patients. Th… Recruiting

2024-516842-21-00 Recurrent ovarian cancer 5 2025-01-09
MITO 35a: a multicenter, prospective, single arm trial of Olaparib maintenance therapy in newly diagnosed BRCA wild-type advanced ovarian, … Recruiting

2024-516839-27-00 BRCA wild-type advanced ovarian, fallopian tube and pri 4 2024-12-09
A study comparing current available therapies with imetelstat for the treatment of intermediate-2 or high-risk MF who are not responding to … Ended

2023-509120-17-00 Myelofibrosis 5 2021-04-12
Phase II multicenter single arm study to evaluate the efficacy and safety of ibrutinib in combination to rituximab-CHOP followed by ibrutini… Ended

2024-511641-18-00 Diffuse Large B-cell Lymphoma ABC 4 2019-08-01